Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology
Published in: European Archives of Oto-Rhino-Laryngology 10/2010

Open Access 01-10-2010 | Review Article

Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review

Authors: Irene Jacobi, Lisette van der Molen, Hermelinde Huiskens, Maya A. van Rossum, Frans J. M. Hilgers

Published in: European Archives of Oto-Rhino-Laryngology | Issue 10/2010

Login to get access

Abstract

Purpose of this review is to systematically assess the effects on voice and speech of advanced head and neck cancer and its treatment by means of chemoradiotherapy (CRT). The databases Medline, Embase and Cochrane were searched (1991–2009) for terms head and neck cancer, chemoradiation, voice and speech rehabilitation. Twenty articles met the inclusion criteria, whereof 14 reported on voice outcomes and 10 on speech. Within the selected 20 studies, 18 different tools were used for speech or voice evaluation. Most studies assessed their data by means of patient questionnaires. Four studies presented outcome measures in more than one dimension. Most studies summarised the outcomes of posttreatment data that were assessed at various points in time after treatment. Except for four studies, pre-treatment measurements were lacking. This and the fact that most studies combined the outcomes of patients with radiated laryngeal cancers with outcome data of non-laryngeal cancer patients impedes an interpretation in terms of the effects of radiation versus the effects of the disease itself on voice or speech. Overall, the studies indicated that voice and speech degenerated during CRT, improved again 1–2 months after treatment and exceeded pre-treatment levels after 1 year or longer. However, voice and speech measures do not show normal values before or after treatment. Given the large-ranged posttreatment data, missing baseline assessment and the lacking separation of tumour/radiation sites, there is an urgent need for structured standardised multi-dimensional speech and voice assessment protocols in patients with advanced head and neck cancer treated with CRT.
Literature
1.
Cognetti DM, Weber RS, Lai SY (2008) Head and neck cancer: an evolving treatment paradigm. Cancer 113:1911–1932CrossRefPubMed
2.
van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Hilgers FJ (2009) Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol 266:901–902CrossRefPubMed
3.
Rosen DC, Sataloff RT (1997) Voice disorders; psychological aspects; patients; rehabilitation; psychology. Singular Publication Group, San Diego
4.
Peeters AJ, van Gogh CD, Goor KM, Verdonck-de Leeuw IM, Langendijk JA, Mahieu HF (2004) Health status and voice outcome after treatment for T1a glottic carcinoma. Eur Arch Otorhinolaryngol 261:534–540CrossRefPubMed
5.
Fung K, Yoo J, Leeper HA, Bogue B, Hawkins S, Hammond JA, Gilchrist JA, Venkatesan VM (2001) Effects of head and neck radiation therapy on vocal function. J Otolaryngol 30:133–139CrossRefPubMed
6.
Fex S, Henriksson B (1969) Phoniatric treatment combined with radiotherapy of laryngeal cancer for the avoidance of radiation damage. Acta Otolaryngol Suppl 263:128–129PubMed
7.
Lehman JJ, Bless DM, Brandenburg JH (1988) An objective assessment of voice production after radiation therapy for stage I squamous cell carcinoma of the glottis. Otolaryngol Head Neck Surg 98:121–129PubMed
8.
van Gogh CD, Verdonck-de Leeuw IM, Boon-Kamma BA, Rinkel RN, de Bruin MD, Langendijk JA, Kuik DJ, Mahieu HF (2006) The efficacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer 106:95–105CrossRefPubMed
9.
Lazarus CL (2009) Effects of chemoradiotherapy on voice and swallowing. Curr Opin Otolaryngol Head Neck Surg 17:172–178CrossRefPubMed
10.
Dejonckere PH, Bradley P, Clemente P, Cornut G, Crevier-Buchman L, Friedrich G, Van De Heyning P, Remacle M, Woisard V (2001) A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS). Eur Arch Otorhinolaryngol 258:77–82CrossRefPubMed
11.
Ackerstaff AH, Tan IB, Rasch CR, Balm AJ, Keus RB, Schornagel JH, Hilgers FJ (2002) Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 128:1185–1190PubMed
12.
Ackerstaff AH, Balm AJ, Rasch CR, de Boer JP, Wiggenraad R, Rietveld DH, Gregor RT, Kroger R, Hilgers FJ (2009) First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck 31:77–84CrossRefPubMed
13.
Boscolo-Rizzo P, Maronato F, Marchiori C, Gava A, Da Mosto MC (2008) Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope 118:300–306CrossRefPubMed
14.
Carrara-de Angelis E, Feher O, Barros AP, Nishimoto IN, Kowalski LP (2003) Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg 129:733–738CrossRefPubMed
15.
Dietz A, Nollert J, Eckel H, Volling P, Schroder M, Staar S, Conradt C, Helmke B, Dollner R, Muller RP, Wannenmacher M, Weidauer H, Rudat V (2002) Organ preservation in advanced laryngeal and hypopharyngeal carcinoma by primary radiochemotherapy. Results of a multicenter phase II study. HNO 50:146–154CrossRefPubMed
16.
Dubois MD, Crevier-Buchman L, Martin C, Prades JM (2006) Epidermoid carcinoma of piriform sinus after chemo-radiotherapy: acoustic evaluation and voice handicap. Rev Laryngol Otol Rhinol (Bord) 127:299–304
17.
El Deiry M, Funk GF, Nalwa S, Karnell LH, Smith RB, Buatti JM, Hoffman HT, Clamon GH, Graham SM, Trask DK, Dornfeld KJ, Yao M (2005) Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg 131:879–885CrossRefPubMed
18.
Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A, Tsien C, Bradford CR, Chepeha DB, Hogikyan ND, Prince ME, Teknos TN, Wolf GT (2005) Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 63:1395–1399CrossRefPubMed
19.
Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY, Suen JY (2004) Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130:875–879CrossRefPubMed
20.
Kazi R, Venkitaraman R, Johnson C, Prasad V, Clarke P, Rhys-Evans P, Nutting CM, Harrington KJ (2008) Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy. Int J Radiat Oncol Biol Phys 70:344–352PubMed
21.
Knab BR, Salama JK, Solanki A, Stenson KM, Cohen EE, Witt ME, Haraf DJ, Vokes EE (2008) Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma. Ann Oncol 19:1650–1654CrossRefPubMed
22.
LoTempio MM, Wang KH, Sadeghi A, Delacure MD, Juillard GF, Wang MB (2005) Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiation vs. total laryngectomy. Otolaryngol Head Neck Surg 132:948–953CrossRefPubMed
23.
Meleca RJ, Dworkin JP, Kewson DT, Stachler RJ, Hill SL (2003) Functional outcomes following nonsurgical treatment for advanced-stage laryngeal carcinoma. Laryngoscope 113:720–728CrossRefPubMed
24.
Mittal BB, Kepka A, Mahadevan A, Kies M, Pelzer H, List MA, Rademaker A, Logemann J (2001) Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers. Int J Cancer 96 Suppl:61–70CrossRefPubMed
25.
Newman LA, Robbins KT, Logemann JA, Rademaker AW, Lazarus CL, Hamner A, Tusant S, Huang CF (2002) Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck 24:68–77CrossRefPubMed
26.
Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL (2004) Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol 22:3061–3069CrossRefPubMed
27.
Orlikoff RF, Kraus DH, Budnick AS, Pfister DG, Zelefsky MJ (1999) Vocal function following successful chemoradiation treatment for advanced laryngeal cancer: preliminary results. Phonoscope 2:67–77
28.
Samant S, Kumar P, Wan J, Hanchett C, Vieira F, Murry T, Wong FS, Robbins KT (1999) Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck 21:595–601CrossRefPubMed
29.
Woodson GE, Rosen CA, Murry T, Madasu R, Wong F, Hengesteg A, Robbins KT (1996) Assessing vocal function after chemoradiation for advanced laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 122:858–864PubMed
30.
Worden FP, Moyer J, Lee JS, Taylor JM, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, Prince ME, Hogikyan N, Lassig AA, Emerick K, Mukherji S, Hadjiski L, Tsien CI, Miller TH, Wallace NE, Mason HL, Bradford CR, Wolf GT (2009) Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope 119:1510–1517CrossRefPubMed
31.
Verdolini K, Titze IR, Fennell A (1994) Dependence of phonatory effort on hydration level. J Speech Hear Res 37:1001–1007PubMed
32.
Verdolini K, Min Y, Titze IR, Lemke J, Brown K, van Mersbergen M, Jiang J, Fisher K (2002) Biological mechanisms underlying voice changes due to dehydration. J Speech Lang Hear Res 45:268–281CrossRefPubMed
33.
Op de Coul BM, Hilgers FJ, Balm AJ, Tan IB, van den Hoogen FJ, van Tinteren H (2000) A decade of postlaryngectomy vocal rehabilitation in 318 patients: a single Institution’s experience with consistent application of provox indwelling voice prostheses. Arch Otolaryngol Head Neck Surg 126:1320–1328PubMed
34.
Friedrich G, Dejonckere PH (2005) The voice evaluation protocol of the European Laryngological Society (ELS)—first results of a multicenter study. Laryngorhinootologie 84:744–752CrossRefPubMed
35.
Verdonck-de Leeuw IM, Hilgers FJ, Keus RB, Koopmans-van Beinum FJ, Greven AJ, de Jong JM, Vreeburg G, Bartelink H (1999) Multidimensional assessment of voice characteristics after radiotherapy for early glottic cancer. Laryngoscope 109:241–248CrossRefPubMed
36.
Middag C, Martens J, Van Nuffelen G, De Bodt M (2009) Automated intelligibility assessment of pahtological speech using phonological features. EURASIP J Adv Signal Process 1–9
37.
Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, Biorklund A, de Leeuw JR, Fayers PM, Jannert M, Westin T, Kaasa S (1999) Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 17:1008–1019PubMed
38.
Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Benninger M, Newman C (1997) The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 6:66–70
39.
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed
40.
Funk GF, Karnell LH, Christensen AJ, Moran PJ, Ricks J (2003) Comprehensive head and neck oncology health status assessment. Head Neck 25:561–575CrossRefPubMed
41.
Hogikyan ND, Sethuraman G (1999) Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice 13:557–569CrossRefPubMed
42.
Hassan SJ, Weymuller EA Jr (1993) Assessment of quality of life in head and neck cancer patients. Head Neck 15:485–496CrossRefPubMed
43.
Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Calais G (2003) Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 55:93–98CrossRefPubMed
44.
Ackerstaff AH, Lindeboom JA, Balm AJ, Kroon FH, Tan IB, Hilgers FJ (1998) Structured assessment of the consequences of composite resection. Clin Otolaryngol Allied Sci 23:339–344CrossRefPubMed
45.
List MA, Ritter-Sterr C, Lansky SB (1990) A performance status scale for head and neck cancer patients. Cancer 66:564–569CrossRefPubMed
46.
Hirano M, McCormick KR (1981) Clinical examination of voice. Springer, New York
47.
Fisher HB, Logemann JA (1971) The Fisher–Logemann test of articulation competence. Houghton Mifflin Co, Boston
Metadata
Title
Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review
Authors
Irene Jacobi
Lisette van der Molen
Hermelinde Huiskens
Maya A. van Rossum
Frans J. M. Hilgers
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 10/2010
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-010-1316-x

Other articles of this Issue 10/2010

European Archives of Oto-Rhino-Laryngology 10/2010 Go to the issue

Head and Neck

Influence of cervical spine stabilization via Stiff Neck on the postural system in healthy patients: compensation or decompensation of the postural system?

Head and Neck

Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma

Otology

Is there a relation between mastoid aeration and Körner’s septum?

Head and Neck

Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal

Laryngology

Microbial colonization of tracheoesophageal voice prostheses (Provox2) following total laryngectomy

Otology

Vestibular disorders among adults in a tertiary hospital in Lagos, Nigeria